Henry Schein Inc
$ 78.85
-1.47%
10 Jun - close price
- Market Cap 9,116,758,000 USD
- Current Price $ 78.85
- High / Low $ 81.21 / 78.78
- Stock P/E 24.18
- Book Value 28.54
- EPS 3.31
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.09 %
- 52 Week High 89.29
- 52 Week Low 61.95
About
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Analyst Target Price
$87.21
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-13 | 2023-08-07 |
| Reported EPS | 1.32 | 1.34 | 1.38 | 0.7 | 0.88 | 1.19 | 1.22 | 1.23 | 1.1 | 0.66 | 1.32 | 1.31 |
| Estimated EPS | 1.22 | 1.3 | 1.28 | 0.92 | 0.9 | 1.2089 | 1.17 | 1.22 | 1.01 | 0.69 | 1.32 | 1.28 |
| Surprise | 0.1 | 0.04 | 0.1 | -0.22 | -0.02 | -0.0189 | 0.05 | 0.01 | 0.09 | -0.03 | 0 | 0.03 |
| Surprise Percentage | 8.1967% | 3.0769% | 7.8125% | -23.913% | -2.2222% | -1.5634% | 4.2735% | 0.8197% | 8.9109% | -4.3478% | 0% | 2.3438% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.23 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HSIC
2026-06-11 12:04:47
Several top Wall Street analysts have upgraded their ratings for five major companies. Henry Schein Inc. saw an upgrade from Neutral to Buy with a $100 price target. Other companies receiving upgrades include Black Hills Corp., Intel Corp., Tronox Holdings PLC, and CME Group Inc., with increased price targets reflecting a bullish outlook from various financial institutions.
2026-06-11 10:30:44
BTIG upgraded Henry Schein (NASDAQ:HSIC) to Buy from Neutral, setting a price target of $100 due to strong first-quarter 2026 U.S. dental growth, healthy market sentiment, and margin expansion. Despite the stock showing a 10.84% return over the past year, InvestingPro suggests it is slightly overvalued relative to its Fair Value. Henry Schein also recently surpassed Q1 2026 earnings and revenue expectations, although concerns about future guidance led to a premarket stock decline.
2026-06-11 10:04:51
BTIG has upgraded Henry Schein (NASDAQ:HSIC) from Neutral to Buy, setting a price target of $100 due to strong dental growth. The firm cited first-quarter 2026 U.S. dental internal growth exceeding estimates, healthy dental markets, and margin expansion. Despite concerns about low medical segment growth and the stock being slightly overvalued, BTIG considers Henry Schein a dental category technology leader.
2026-06-10 17:17:00
Shares of Henry Schein Inc. (HSIC) fell 1.47% to $78.85 on Wednesday, ending a four-day winning streak. This occurred during a broad market downturn where the S&P 500 Index dropped 1.62% and the Dow Jones Industrial Average fell 1.87%. Despite the daily loss, the article title suggests the stock outperformed its competitors.
2026-06-10 08:10:08
KB Kookmin Bank has issued a $100 million blockchain-based digital bond in Hong Kong, marking the first time a Korean bank has used blockchain for foreign currency funding. This digital bond issuance, which shortened the settlement period from five to three days, was executed via HSBC's Orion platform. It represents a significant step in KB Financial Group's digital financial transformation efforts, streamlining procedures and reducing settlement default risk.
2026-06-09 19:01:01
The dental technology sector outperformed expectations in Q1 2026, with major companies exceeding analyst revenue forecasts despite economic uncertainties. This growth is driven by long-term trends like digital dentistry and AI, even as companies face challenges from inflation and regulatory pressures. Companies like Align Technology, Envista Holdings, Henry Schein, and Dentsply Sirona all reported strong revenue, with Envista showing the highest growth.
